Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-19

Clinical Trial Update: Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients? [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether intravenous ondansetron reduces itch after intrathecal morphine in pediatric patients has been terminated; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

Sponsor: University of Michigan | Conditions: Pruritus, Nausea/Vomiting | Phase 4 | Status: TERMINATED | Results posted: 2021-01-19